Services
Research
Training
Industry
About us
ChEBI
Examples:
iron*
,
InChI=1S/CH4O/c1-2/h2H,1H3
,
caffeine
Advanced
Home
Advanced Search
Browse
Documentation
Download
Tools
About ChEBI
Submit
Contact us
DiNA
Statistics
Entity of the Month
Periodic Table
Ontology
Train online
User Manual
Annotation Manual
Developer Manual
FAQ's
BiNChE
libChEBI
Web Services
ChEBI
> ChEBI Ontology
CHEBI:135775 - mosapramine
Main
ChEBI Ontology
Automatic Xrefs
Reactions
Pathways
Models
ChEBI Name
mosapramine
ChEBI ID
CHEBI:135775
Definition
A racemate comprising equimolar amounts of (
R
)- and (
S
)-mosapramine. It is a second-generation antipsychotic used for the treatment of schizophrenia.
Stars
This entity has been manually annotated by the ChEBI Team.
Roles Classification
Biological Role
(s):
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
Application
(s):
second generation antipsychotic
Antipsychotic drugs which can have different modes of action but which tend to be less likely than first generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements.
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
Graph View
Tree View
CHEBI:24431 chemical entity
CHEBI:23367 molecular entity
CHEBI:33579 main group molecular entity
CHEBI:33675 p-block molecular entity
CHEBI:33582 carbon group molecular entity
CHEBI:50860 organic molecular entity
CHEBI:72695 organic molecule
CHEBI:33832 organic cyclic compound
CHEBI:51958 organic polycyclic compound
CHEBI:51959 organic tricyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:24532 organic heterocyclic compound
CHEBI:38166 organic heteropolycyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:38101 organonitrogen heterocyclic compound
CHEBI:35624 azaspiro compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:33285 heteroorganic entity
CHEBI:24532 organic heterocyclic compound
CHEBI:38166 organic heteropolycyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:38101 organonitrogen heterocyclic compound
CHEBI:35624 azaspiro compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:35352 organonitrogen compound
CHEBI:38101 organonitrogen heterocyclic compound
CHEBI:35624 azaspiro compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:50047 organic amino compound
CHEBI:50996 tertiary amino compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:17792 organohalogen compound
CHEBI:36683 organochlorine compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:50047 organic amino compound
CHEBI:50996 tertiary amino compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:33302 pnictogen molecular entity
CHEBI:51143 nitrogen molecular entity
CHEBI:35352 organonitrogen compound
CHEBI:38101 organonitrogen heterocyclic compound
CHEBI:35624 azaspiro compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:50047 organic amino compound
CHEBI:50996 tertiary amino compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:24471 halogen molecular entity
CHEBI:37578 halide
CHEBI:17792 organohalogen compound
CHEBI:36683 organochlorine compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:23117 chlorine molecular entity
CHEBI:36683 organochlorine compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:36357 polyatomic entity
CHEBI:25367 molecule
CHEBI:72695 organic molecule
CHEBI:33832 organic cyclic compound
CHEBI:51958 organic polycyclic compound
CHEBI:51959 organic tricyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:24532 organic heterocyclic compound
CHEBI:38166 organic heteropolycyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:38101 organonitrogen heterocyclic compound
CHEBI:35624 azaspiro compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:33595 cyclic compound
CHEBI:33832 organic cyclic compound
CHEBI:51958 organic polycyclic compound
CHEBI:51959 organic tricyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:24532 organic heterocyclic compound
CHEBI:38166 organic heteropolycyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:38101 organonitrogen heterocyclic compound
CHEBI:35624 azaspiro compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:33635 polycyclic compound
CHEBI:51958 organic polycyclic compound
CHEBI:51959 organic tricyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:33671 heteropolycyclic compound
CHEBI:36688 heterotricyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:38166 organic heteropolycyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:33599 spiro compound
CHEBI:35624 azaspiro compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:5686 heterocyclic compound
CHEBI:33671 heteropolycyclic compound
CHEBI:36688 heterotricyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:38166 organic heteropolycyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:24532 organic heterocyclic compound
CHEBI:38166 organic heteropolycyclic compound
CHEBI:26979 organic heterotricyclic compound
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:38101 organonitrogen heterocyclic compound
CHEBI:35624 azaspiro compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:47804 dibenzoazepine
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:37577 heteroatomic molecular entity
CHEBI:37578 halide
CHEBI:17792 organohalogen compound
CHEBI:36683 organochlorine compound
CHEBI:166972 1'-[3-(3-chloro-10,11-dihydro-5
H
-dibenzo[
b
,
f
]azepin-5-yl)propyl]hexahydro-2
H
-spiro[imidazo[1,2-
a
]pyridine-3,4'-piperidin]-2-one
CHEBI:166970 (
S
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:166971 (
R
)-mosapramine
CHEBI:135775 mosapramine
CHEBI:59999 chemical substance
CHEBI:60004 mixture
CHEBI:60911 racemate
CHEBI:135775 mosapramine
CHEBI:50906 role
CHEBI:33232 application
CHEBI:52217 pharmaceutical
CHEBI:23888 drug
CHEBI:35470 central nervous system drug
CHEBI:35471 psychotropic drug
CHEBI:35473 tranquilizing drug
CHEBI:35476 antipsychotic agent
CHEBI:65191 second generation antipsychotic
CHEBI:135775 mosapramine
CHEBI:35488 central nervous system depressant
CHEBI:35473 tranquilizing drug
CHEBI:35476 antipsychotic agent
CHEBI:65191 second generation antipsychotic
CHEBI:135775 mosapramine
CHEBI:35942 neurotransmitter agent
CHEBI:48560 dopaminergic agent
CHEBI:48561 dopaminergic antagonist
CHEBI:135775 mosapramine
CHEBI:24432 biological role
CHEBI:52210 pharmacological role
CHEBI:35942 neurotransmitter agent
CHEBI:48560 dopaminergic agent
CHEBI:48561 dopaminergic antagonist
CHEBI:135775 mosapramine
CHEBI:48706 antagonist
CHEBI:48561 dopaminergic antagonist
CHEBI:135775 mosapramine
Relationship Types
is a
has part
is conjugate base of
is conjugate acid of
is tautomer of
is enantiomer of
has functional parent
has parent hydride
is substituent group from
has role
Status
Checked
Unchecked